


GyreOx Email Formats
Biotechnology Research • Oxford, England, United Kingdom • 1-10 Employees
Key Contact at GyreOx
Bill Primrose
CEO
Company overview
| Headquarters | Oxford, England, United Kingdom |
| Phone number | +441223247468 |
| Website | |
| NAICS | 541714 |
| Keywords | Enzymes, Peptides, Combinatorial Chemistry, Chemical Biology, Macrocycles, Gyrocycles |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
About GyreOx
Bringing new therapeutics to patients via our unique macrocyclic drug discovery platform. GyreOx Limited is a 2019 spinout from the University of Oxford. Incorporated on 20 May 2019, with the laboratories located at the Harwell Campus in Oxfordshire. GyreOx’s platform technology is a combined chemistry / synthetic biology process, protected by 4 patent applications, allowing rapid access to novel and drug-like gyrocycles for hit-to-lead drug discovery. Our proprietary discovery platform is used to create unique and highly modified macrocyclic compounds called ‘gyrocycles’. Gyrocycles combine the target-engagement power of biologics with the cell-entry ability of small molecules.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GyreOx has 1 employees across 1 departments.
Departments
Number of employees
GyreOx Tech Stack
Discover the technologies and tools that power GyreOx's digital infrastructure, from frameworks to analytics platforms.
CDN
Programming languages
Miscellaneous
JavaScript libraries
CDN
Frequently asked questions
4.8
40,000 users



